Company: ZLAB
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001628280-25-038548
Chunk: 30

Company: Zai Lab Ltd
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 30
---
Item 1. Financial Statements.

Zai Lab Limited 

Unaudited Condensed Consolidated Balance Sheets 

(in thousands of U.S. dollars (“$”), except for number of shares and per share data) 

NotesJune 30,2025December 31,2024AssetsCurrent assetsCash and cash equivalents3732,159 449,667 Restricted cash, current100,111 100,000 Short-term investments— 330,000 Accounts receivable (net of allowance for credit losses of $26 and $25 as of June 30, 2025 and December 31, 2024, respectively)88,499 85,178 Notes receivable10,843 4,233 Inventories, net461,700 39,875 Prepayments and other current assets40,750 41,527 Total current assets1,034,062 1,050,480 Restricted cash, non-current1,114 1,114 Property and equipment, net550,160 47,961 Operating lease right-of-use assets16,787 21,496 Land use rights, net2,860 2,907 Intangible assets, net656,519 56,027 Other non-current assets2,599 5,768 Total assets1,164,101 1,185,753 Liabilities and shareholders’ equity  Current liabilities  Accounts payable107,357 100,906 Current operating lease liabilities5,584 8,048 Short-term debt10174,509 131,711 Other current liabilities1144,051 58,720 Total current liabilities331,501 299,385 Deferred income29,233 31,433 Non-current operating lease liabilities11,307 13,712 Other non-current liabilities325 325 Total liabilities372,366 344,855 Commitments and contingencies (Note 17)  Shareholders’ equity  Ordinary shares (par value of $0.000006 per share; 5,000,000,000 shares authorized; 1,104,032,910 and 1,082,614,740 shares issued as of June 30, 2025 and December 31, 2024, respectively; 1,099,112,890 and 1,077,702,540 shares outstanding as of June 30, 2025 and December 31, 2024,